| J9271 | Injection, pembrolizumab, 1 mg | 11,000 | $40 | $473K |
| J0897 | Injection, denosumab, 1 mg | 5,340 | $20 | $101.5K |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 2,130 | $30 | $70.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 380 | $90 | $35.7K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 290 | $100 | $29.6K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 13,800 | $1 | $27.6K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 370 | $60 | $23.4K |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 40 | $360 | $13.8K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 210 | $50 | $10.4K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 80 | $130 | $10K |